Jennifer Larson
CIK: 0002149587
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCAX
Bicara Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Larson Jennifer
Larson Jennifer (SEC CIK 0002149587) files insider reports with the SEC as Chief Financial Officer of Bicara Therapeutics Inc. (BCAX).
Signal8 holds 2 ownership filings by Larson Jennifer (1 Form 3, 1 Form 4), filed on Aug 14, 2026. Those filings report 1 transaction, the latest on Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Larson Jennifer's filings is in BOSTON, MA.
Recent filings by Larson Jennifer
- Aug 12, 2026: Grant or award of BCAX derivative securities (Form 4, code A).
Other insiders filing for Bicara Therapeutics Inc. (BCAX)
- Cohlhepp Ryan, President, COO & Interim CEO
- Hyep Ivan, Chief Financial Officer
- Mazumdar Claire, Chief Executive Officer
- Bender Jeremy, Director
- Oliger Christy J., Director
- RA CAPITAL MANAGEMENT, L.P., Director